About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Updates from ASH in Later Line Multiple Myeloma Management
Updates from ASH in Later Line Multiple Myeloma Management
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
Experts Discuss How to Choose Between CAR-Ts and Bispecifics in Myeloma
By
MyCancerHaven
FEATURING
Ravi Vij
,
Nitya Nathwani
By
MyCancerHaven
FEATURING
Ravi Vij
,
Nitya Nathwani
175 views
May 2, 2024
0 Comments
Login to view comments.
Click here to Login
Updates from ASH in Later Line Multiple Myeloma Management
22:50
MyCancerHaven
Experts Discuss How to Choose Between CAR-Ts and Bispecifics in Myel…
Feat.
R. Vij,
N. Nathwani
14:34
Krina Patel
Early Line CAR-Ts in Myeloma - Updates and Future Directions
03:42
Moffitt Cancer Center
New FDA Approvals of CAR-Ts Earlier in Myeloma: What You Need to Know
Feat.
D. Hansen
22:50
Indy Hematology Review
Emerging and Cellular Therapeutic Options for MM: Understanding Your…
Feat.
S. Usmani
50:49
UChicago Medicine
Car T-Cells and Bispecifics in Myeloma: A Case for Moving Them Early
Feat.
N. Raje
21:14
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates on the Role of Immunotherapy for MM
Feat.
A. Cohen
24:29
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
How I Treat R/R MM With CAR-T and Bispecific Antibodies
Feat.
C. Cerchione
25:42
5th SOHO Italy Annual Conference
SOHO Italy 2023: New Insights and Opportunities for Lenalidomide Ref…
Feat.
J. San-Miguel
06:14
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Inflammatory Biomarkers and Outcomes in MM …
Feat.
D. Pan
08:11
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-3 Trial - Ide-Cel vs. Standard Regim…
Feat.
K. Patel
04:30
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-2 Extended Follow-Up - Ide-Cel in Pt…
Feat.
M. Alsina
09:05
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-3 Trial - Effects of Ide-Cel vs. Sta…
Feat.
M. Delforge
49:01
Scripps MD Anderson Cancer Center
Current Summary of the Multiple Myeloma Treatment Landscape
Feat.
R. Lu
24:39
Icahn School of Medicine at Mount Sinai
Adverse Effects of CAR-T: Myeloma Edition
Feat.
S. Rajeeve
